Literature DB >> 6144546

The multiple modes of action of propafenone.

I D Dukes, E M Vaughan Williams.   

Abstract

Previous studies of widely different concentrations of propafenone in various species have reported that in addition to having class 1 antiarrhythmic action, the drug was a beta adrenoceptor blocker and a calcium antagonist. High concentration shortened action potential duration in animal experiments, but Q-T interval was reported as being lengthened in man. It was thought desirable to study the effects of propafenone over a range of concentrations equivalent to those used clinically in various cardiac tissues of a single species, the rabbit. It was concluded that although the primary action of propafenone was on fast inward current, the drug being categorised as of group 1c, its potency as a beta blocker was sufficient for the effect to be of clinical significance. Its potency as a calcium antagonist was relatively weak. Action potential duration and effective refractory period were lengthened in both atrium and ventricle, the effects being long-lasting and persisting on wash-out of the drug when other measurements had returned to control values.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6144546     DOI: 10.1093/oxfordjournals.eurheartj.a061621

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  25 in total

Review 1.  Therapeutic drug monitoring: antiarrhythmic drugs.

Authors:  T J Campbell; K M Williams
Journal:  Br J Clin Pharmacol       Date:  1998-10       Impact factor: 4.335

Review 2.  Antiarrhythmic therapy in atrial fibrillation: indications, guidelines, and safety.

Authors:  Armin Barekatain; Mehdi Razavi
Journal:  Tex Heart Inst J       Date:  2012

Review 3.  Oral loading with propafenone for conversion of recent-onset atrial fibrillation: a review on in-hospital treatment.

Authors:  Giuseppe Boriani; Cristian Martignani; Mauro Biffi; Alessandro Capucci; Angelo Branzi
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 4.  Anti-Arrhythmic Agents in the Treatment of Atrial Fibrillation.

Authors:  Omar F Hassan; Jassim Al Suwaidi; Amar M Salam
Journal:  J Atr Fibrillation       Date:  2013-06-30

Review 5.  Propafenone. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in cardiac arrhythmias.

Authors:  H M Bryson; K J Palmer; H D Langtry; A Fitton
Journal:  Drugs       Date:  1993-01       Impact factor: 9.546

6.  Functional and metabolic effects of propafenone in the rat heart-lung preparation.

Authors:  S Kashimoto; T Oguchi; T Nakamura; T Kumazawa
Journal:  J Anesth       Date:  1991-10       Impact factor: 2.078

7.  Effects of propafenone on 45Ca movements and contractile responses in vascular smooth muscle.

Authors:  R Carrón; F Pérez-Vizcaino; E Delpón; J Tamargo
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

Review 8.  New antiarrhythmic drugs in pediatric use: propafenone.

Authors:  T Paul; J Janousek
Journal:  Pediatr Cardiol       Date:  1994 Jul-Aug       Impact factor: 1.655

9.  Effects of propafenone on electrical and mechanical activities of single ventricular myocytes isolated from guinea-pig hearts.

Authors:  H Honjo; T Watanabe; K Kamiya; I Kodama; J Toyama
Journal:  Br J Pharmacol       Date:  1989-07       Impact factor: 8.739

10.  Effects of 5-hydroxy-propafenone in guinea-pig atrial fibres.

Authors:  C Delgado; J Tamargo; T Tejerina; C Valenzuela
Journal:  Br J Pharmacol       Date:  1987-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.